Related Experiment Video
Updated: Apr 5, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Practical issues in the management of tuberculosis disease]
C Guimond1, J-P Orain2, M Tanguy3
1Médecin conseil régional, régime social des indépendants (RSI) Île-de-France, 75847 Paris cedex 17, France.
This study found that many tuberculosis patients did not receive standard treatment, indicating a gap in knowledge of High Authority for Health (HAS) guidelines. Adherence to recommended therapies and treatment durations was suboptimal in the surveyed population.
Area of Science:
- Public Health
- Infectious Diseases
- Medical Guidelines
Background:
- Tuberculosis (TB) management requires adherence to standard therapeutic guidelines.
- The High Authority for Health (HAS) provides guidelines for TB treatment in France.
Purpose of the Study:
- To assess the adherence to standard tuberculosis treatment guidelines.
- To identify deviations from recommended care pathways and treatment protocols.
Main Methods:
- A national survey was conducted by the medical services of the régime social des indépendants (RSI).
- Patients reimbursed for TB treatment or admitted for long-term TB in 2011 were targeted.
- Physicians were contacted to detail patient care pathways and treatments received.
Main Results:
- Out of 148 TB patients, 71.6% had respiratory TB; 84.5% were diagnosed in healthcare institutions.
- Standard treatment (phases 1 and 2) was used in only 30.1% of cases.
- Adherence to recommended quadruple therapy in phase 1 was 55.2%, and timely administration was 62.9%; phase 2 adherence was 80.4%, with duration respected in 51.0%.
Conclusions:
- The survey revealed a relative lack of knowledge regarding standard TB treatment as recommended by the HAS.
- Deviations from standard treatment were infrequently explained by detected health or social events (39.0%).
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

